Your web browser is out of date. Update your browser for more security, speed and the best experience on this site.

Update your browser

Set your sights on target-based drug discovery.

Unlock the power of multi-omics and clinical data to accelerate target identification, find biomarkers, and deliver the next generation of drugs and treatments.

Hero industry pharma

New White Paper! Transform omics data into novel drug targets with these four critical strategies.

WHY DNAnexus

Make Precision Medicine a Reality

Transforming omics data into groundbreaking discoveries and targeted treatments relies on its integration with a range of clinical data types. Most informatics tools can't cope with the size and complexity of these datasets. DNAnexus empowers researchers to draw critical insights from even the largest, most diverse datasets - so they can deliver on the promise of precision medicine.

Accelerate Discovery

To extract actionable insights, pharma and biotech R&D teams need to collaborate efficiently in analyzing enormous volumes of data. DNAnexus eliminates bottlenecks with a robust informatics solution, designed for enhanced collaboration, to accelerate research workflows for R&D teams around the world.

Reduce Your Compliance Risk

Complying with security standards and privacy regulations is an increasingly complex job. DNAnexus simplifies security and compliance for critical business operations, enabling you to focus on the science. The DNAnexus Platform is in compliance with ISO 27001, HIPAA, CAP/CLIA, GxP, FedRAMP, GDPR, and more.


Integrate Diverse Data

Reach meaningful insights faster with the ability to seamlessly analyze related datasets together - including omics, phenotype, imaging data, and more. Leverage public population-scale datasets, like UK Biobank, or bring in your own.

Supercharge Collaboration

Data scientists, computational biologists, and clinician researchers can iterate in real-time by sharing projects, data, and analysis results - all within a secure and complaint environment with robust role-based permissioning, and comprehensive access controls.

Define Research Cohorts

Make cohort selection a breeze. Researchers can create, compare, and share virtual cohorts for hypothesis vetting and downstream analysis, all within an intuitive interface that’s equally accessible to both bench scientists and informaticians.

Conduct Powerful Analysis

Run batch analysis with ease, using robust, scalable, and ready-to-use pipelines, or bring in your own custom tools. Select from a range of charts and visualizations, like Manhattan Plots and Kaplan-Meier Plots, to create meaningful, actionable views of your results. Take your analyses further in a JupyterLab Notebook - without leaving the DNAnexus environment.

De-Risk Clinical Trials

Integrate omics data to improve clinical trial results, and reduce time and cost of clinical development, with a unified GxP compliant platform that spans from research and development to regulated clinical environments.

Future-Proof Innovation

Invest in technology that keeps pace with your high velocity project evolution. DNAnexus is committed to innovation, empowering forward-thinking industry leaders in their pursuit of new drug development and better patient care.


Latest News, Case-Studies, White Papers, Webinars & More.

Sign up for our monthly newsletter to learn about the latest DNAnexus initiatives and gain exclusive access to new tools and product launches.

"You save the bioinformatician’s time as well as compute time, and therefore decrease turnaround time. This enables R&D researchers to answer questions and get rare disease treatments to market faster. You can’t put a price tag on that."


"DNAnexus is an important partner helping us navigate the complexities of integrating genotype and phenotype data to deliver improved insights to our leading R&D teams."

Executive Director, Head of Genome Informatics
Regeneron Genetics Center

"DNAnexus offers the most comprehensive security and privacy framework, providing our global labs auditability, data immutability, and scalability to integrate genome-based biomarker delivery in clinical trials."

Vice President Data Sciences & Biostatistics
Almac Diagnostics

"DNAnexus allows us to progress towards our goal of analysing two million genomes. We look forward to continue working together to advance the future of personalised healthcare and develop the most impactful treatments for patients."

VP, Personalized Healthcare & Biomarkers


Learn how easy it is to unlock the power of multi-omics and clinical data for advanced drug discovery.

I consent to the use of cookies by DNAnexus and necessary third parties in accordance to the Privacy Policy and Terms of Services. DNAnexus may use third-party services for this purpose. I can revoke my consent anytime by visiting the Cookies Settings page.